The Obesogen Hypothesis of Obesity: Overview and Human Evidence

  • Jerrold J. HeindelEmail author
Part of the Endocrine Updates book series (ENDO, volume 30)


Obesity, like all complex diseases, is believed to have both a genetic and an environmental component. Data supporting an important role for environment in obesity come from the recent rise in the incidence of obesity over the past few decades. This review will present a new hypothesis for the etiology of obesity: the obesogen hypothesis. This emerging hypothesis states that susceptibility to develop obesity is due to exposure to environmental chemicals during development in utero and the first few years of life. Proof of principle for this hypothesis comes from smoking during pregnancy, which results in increased weight gain in children. There are examples using animal models for developmental exposures to chemicals with estrogenic activity [diethylstilbestrol, genistein (soy phytoestrogen) and bisphenol A (polycarbonate), tributyltin (a component of PVC)] and several pesticides resulting in increased weight gain later in life. An important aspect of the obesogen hypothesis is that obesity due to environmental exposure can be prevented by reducing exposure. Thus, this new hypothesis changes the focus from treatment to prevention of obesity.


Developmental programming Obesogens Developmental basis of disease Environmental chemicals Epidemiology studies Obesity set point Obesity prevention 


  1. 1.
    NHANES Data on the Prevalence of Overweight Among Children and Adolescents: United States. 2003–2006. CDC National Center for Health Statistics, Health E-Stat.Google Scholar
  2. 2.
    Kim J, Peterson KE, Scanlon KS, Fitzmaurice GM, Must A, Oken E, Rifas-Shiman SL, Rich-Edwards JW, Gillman MW. Trends in overweight from 1980 through 2001 among preschool-aged children enrolled in a health maintenance organization. Obesity. 2006;14:1107–2.PubMedCrossRefGoogle Scholar
  3. 3.
    Loos RJF. Recent progress in the genetics of common obesity. Br J Clin Pharm. 2009;68:811–29.CrossRefGoogle Scholar
  4. 4.
    Hill AJ. Does dieting make you fat? Br J Nutr. 2004;92:S15–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Wadhwa PD, Buss C, Entringer S, Swanson JM. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med. 2009;27:358–68.PubMedCrossRefGoogle Scholar
  6. 6.
    Barker DJ. The origins of the developmental origins theory. J Intern Med. 2007;261:412–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Gluckman PD, Hanson MA, Pinal C. The developmental origins of adult disease. Matern Child Nutr. 2005;1(3):130–41.PubMedCrossRefGoogle Scholar
  8. 8.
    Gluckman PD, Hanson MA, Beedle AS, Raubenheimer D. Fetal and neonatal pathways to obesity. Front Horm Res. 2008;36:61–72.PubMedCrossRefGoogle Scholar
  9. 9.
    Fall C. Maternal nutrition: effects on health in the next generation. Indian J Med Res. 2009;130:593–9.PubMedGoogle Scholar
  10. 10.
    Wright CS, Rifas-Shiman SL, Rich-Edwards JW, Taveras EM, Gillman MW, Oken E. Intrauterine exposure to gestational diabetes, childhood adiposity, and blood pressure. Am J Hypertens. 2009;22:215–20.PubMedCrossRefGoogle Scholar
  11. 11.
    Oken E, Gillman MW. Fetal origins of obesity. Obes Res. 2003;11:496–506.PubMedCrossRefGoogle Scholar
  12. 12.
    Stettler N, Stallings VA, Troxel AB, Zhao J, Schinnar R, Nelson SE, Ziegler EE, Strom SJ. Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula. Circulation. 2005;111:1897–903.PubMedCrossRefGoogle Scholar
  13. 13.
    Stettler N. Nature and strength of epidemiological evidence for origins of childhood and adulthood obesity in the first year of life. Int J Obes. 2007;31:1035–43.CrossRefGoogle Scholar
  14. 14.
    Newbold RR, Heindel JJ. Developmental exposures and implications for early and latent disease. In: Woodruff TJ, Janssen SJ, Guillette LJ and Giudice LC editors. Environmental impacts on reproductive health and fertility. Cambridge University Press; New York, NY 2010. pp. 92–102.Google Scholar
  15. 15.
    Newbold RR, Heindel JJ. Developmental origins of health and disease: the importance of environmental exposures. In: Newnham JP and Ross MD editors. Early life origins of human health and disease. Karger Press, Basel, Switzerland 2009. pp. 41–50.Google Scholar
  16. 16.
    Grandjean P. PPTOX prenatal programming and toxicity. Basic Clin Pharmacol Toxicol. 2008;102(2):1–273.Google Scholar
  17. 17.
    Grun F, Blumberg B. Minireview: the case for obesogens. Mol Endocrinol. 2009;23:1127–34.PubMedCrossRefGoogle Scholar
  18. 18.
    Heindel JJ, vom Saal FS. Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity. Mol Cell Endocrinol. 2009;304:90–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Newbold R, Padilla-Banks E, Jefferson W. Molecular and cellular endocrinology. Mol Cell Endocrinol. 2009;304:84–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Edwards JR, Prozialeck WC. Cadmium, diabetes and chronic kidney disease. Toxicol Appl Pharmacol. 2009;238:289–93.PubMedCrossRefGoogle Scholar
  21. 21.
    Longnecker MP, Daniels JL. Environmental contaminants as etiologic factors for diabetes. Environ Health Perspect. 2001;109 Suppl 6:871–6.PubMedGoogle Scholar
  22. 22.
    Tseng CH. The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicol Appl Pharmacol. 2004;197:67–83.PubMedCrossRefGoogle Scholar
  23. 23.
    Schwartz GG, Il’yasova D, Ivanova A. Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care. 2003;26:468–70.PubMedCrossRefGoogle Scholar
  24. 24.
    Uemura H, Arisawa K, Hiyoshi M, Kitayama A, Takami H, Sawachika F, Dakeshita S, Nii K, Satoh H, Sumiyoshi Y, Morinaga K, Kodama K, Suzuki T, Nagai M, Suzuki T. Prevalence of metabolic syndrome associated with body burden levels of dioxin and related compounds among Japan’s general population. Environ Health Perspect. 2009;117:568–73.PubMedGoogle Scholar
  25. 25.
    Pozharny Y, Lambertini L, Clunie G, Ferrara L, Lee M-J. Epigenetics in women’s health care. Mt Sinai J Med. 2010;77:225–35.PubMedCrossRefGoogle Scholar
  26. 26.
    Bollati V, Baccarelli A. Environmental epigenetics. Heredity. 2010;105(1):105–12. Feb 24 2010; [Epub ahead of print].PubMedCrossRefGoogle Scholar
  27. 27.
    Heijmans BT, Tobi EW, Lumey LH, Slagboom PE. The epigenome, archive of the prenatal environment. Epigenetics. 2009;4:1–6.CrossRefGoogle Scholar
  28. 28.
    van der Meulen Jan. Commentary: maternal smoking during pregnancy and obesity in the offspring. Int J Epidemiol. 2002;31:420–1.PubMedCrossRefGoogle Scholar
  29. 29.
    Oken E, Levitan E, Gillman M. Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis. Int J Obes. 2008;32:201–10.CrossRefGoogle Scholar
  30. 30.
    Toschke AM, Montgomery SM, Pfeiffer U, von Kries R. Early intrauterine exposure to tobacco-inhaled products and obesity. Am J Epidemiol. 2003;158:1068–74.PubMedCrossRefGoogle Scholar
  31. 31.
    Verhulst SL, Nelen V, Hond ED, Kiippen G, Beunckens C, Vael C, Schoeters G, Desager K. Intrauterine exposure to environmental pollutants and body mass index during the first 3 years of life. Environ Health Perspect. 2009;117:122–6.PubMedGoogle Scholar
  32. 32.
    Smink A, Ribas-Fito N, Garcia R, Torrent M, Mendez MA, Grimalt JO, Sunyer J. Exposure to hexachlorobenzene during pregnancy increases the risk of overweight in children aged 6 years. Acta Paediatr. 2008;97:1465–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Chen A, Pennell M, Klebanoff M, et al. Maternal smoking during pregnancy in relation to child overweight: follow-up to age 8 years. Int J Epidemiol. 2006;35:121–30.PubMedCrossRefGoogle Scholar
  34. 34.
    Power C, Jefferis B. Fetal environment and subsequent obesity: a study of material smoking. Int J Epidemiol. 2002;31:413–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Syme C, Abrahamowicz M, Mahboubi A, et al. Prenatal exposure to maternal cigarette smoking and accumulation of intra-abdominal fat during adolescence. Obesity. 2009;18(5):1021–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Sharma AJ, Cogswell ME, Li R. Dose-response associations between maternal smoking during pregnancy and subsequent childhood obesity: effect modification by maternal race/ethnicity in a low-income US cohort. Am J Epidemiol. 2008;168(9):995–1007.PubMedCrossRefGoogle Scholar
  37. 37.
    Huang JS, Lee TA, Lu MC. Prenatal programming of childhood overweight and obesity. Matern Child Health. 2007;11:461–73.CrossRefGoogle Scholar
  38. 38.
    Hertz-Picciotto I, Charles MJ, James RA, Keller JA, Willman E, Teplin S. In utero polychlorinated biphenyl exposures in relation to fetal and early childhood growth. Epidemiology. 2005;16:648–56.PubMedCrossRefGoogle Scholar
  39. 39.
    Perez-Pozo SE, Schold J, Nakagawa T, Sanchez-Lozada LG, Johnson RJ, Lillo JL. Excessive fructose intake induces the features of metabolic syndrome in health adult men: role of uric acid in the hypertensive response. Int J Obes. 2010;34:454–61.CrossRefGoogle Scholar
  40. 40.
    Bantle JP. Dietary fructose and metabolic syndrome and diabetes. J Nutr. 2009;139:1263S–8S.PubMedCrossRefGoogle Scholar
  41. 41.
    Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol. 2010;7(5):251–64 [April 6 ahead of print].PubMedCrossRefGoogle Scholar
  42. 42.
    Banks WA, Coon AB, Robinson SM, Moinuddin A, Shultz JM, Nakaoke R, et al. Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes. 2004;53:1253–60.PubMedCrossRefGoogle Scholar
  43. 43.
    Dawson R. Developmental and sex-specific effects of low dose neonatal monosodium glutamate administration on mediobasal hypothalamic chemistry. Neuroendocrinology. 1986;42:158–66.PubMedCrossRefGoogle Scholar
  44. 44.
    He K, Daviglus ML, Dyer AR, Van Horn L, Garside D, Zhu L, Guo D, Wu Y, Shou B, Stamler J. INTERMAP Cooperative Research Group Association of monosodium glutamate intake with overweight in Chinese adults: the INTERMAP study. Obesity. 2008;16:1875–80.PubMedCrossRefGoogle Scholar
  45. 45.
    Desvergne B, Feige JN, Casals-Sasas C. PPAR-mediated activity of phthalates: a link to the obesity epidemic?. Mol Cell Endo. 2009;304:43–8.CrossRefGoogle Scholar
  46. 46.
    Hatch E, Nelson J, Stahlhut R, et al. Association of endocrine disruptors and obesity: perspectives from epidemiological studies. Int J Andrology. Jan 22 2010;33(2):324–32.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Division of Extramural Research and TrainingNational Institute of Environmental Health SciencesResearch Triangle ParkUSA

Personalised recommendations